Invention Publication
- Patent Title: LILRB1 AND LILRB2-BINDING MOLECULES AND USES THEREFOR
-
Application No.: US18549897Application Date: 2022-03-11
-
Publication No.: US20240150462A1Publication Date: 2024-05-09
- Inventor: Richard BROKX , Jacqueline M. MASON , Mark Robert BRAY , Gordon S. DUNCAN
- Applicant: UNIVERSITY HEALTH NETWORK
- Applicant Address: CA TORONTO
- Assignee: UNIVERSITY HEALTH NETWORK
- Current Assignee: UNIVERSITY HEALTH NETWORK
- Current Assignee Address: CA TORONTO
- International Application: PCT/CA22/50363 2022.03.11
- Date entered country: 2023-09-08
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K45/06 ; A61K39/00
Abstract:
The invention provides novel anti-LILR antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer, autoimmune disease, or allergic inflammation.
Information query
